Sept 7 (Reuters) – Neurizon Therapeutics Ltd: * NEURIZON APPOINTS CHIEF EXECUTIVE OFFICER * APPOINTS CHRIS BREMER AS CEO EFFECTIVE 1 OCTOBER 2026 Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)